Requires physicians and other prescribers to obtain electronic or written consent for certain medications with "black box warnings."

S 326 requires physicians, physician assistants, and advanced practice nurses to obtain electronic or written informed consent from patients (or their legal guardians) before prescribing psychotropic medications with FDA "black box warnings" - such as those for ADHD or attention disorders - after explaining potential serious side effects. If written consent isn't possible, prescribers must document oral consent in the patient's file. Violations could lead to disciplinary action by New Jersey's medical or nursing licensing boards. The bill specifically targets medications requiring the FDA's strongest warning for significant health risks.